Canrenone

976-71-6

C22H28O3

DMSO : >= 100 mg/mL (293.72 mM)

Metabolic Enzyme/Protease

Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent. IC50 & Target: Target: Aldosterone^[1] In Vitro: Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner^[1]. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na⁺/H⁺ exchanger 1 induced by platelet-derived growth factor^[2]. In Vivo: Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone^[3].